Arbitrage vs Balance-Sheet CLOs – Same Vehicle, Different Destination

Arbitrage vs Balance-Sheet CLOs – Same Vehicle, Different Destination

If you’ve ever wondered how two transactions can look identical on paper yet serve totally different purposes, welcome to the curious world of the collateralised loan obligation (CLO).
Whether it’s chasing yield or trimming regulatory fat, every CLO has a motive. The trick lies in spotting which one you’re looking at.

The Building Blocks

A CLO is, at heart, a highly organised box of loans. It’s a form of securitisation – a fancy word for bundling up lots of loans, sticking a bow on top, and selling pieces of the bundle to investors. Everyone gets a slice; not everyone gets the same slice of risk.

The whole show starts with a Special Purpose Vehicle (SPV), a company created purely to hold a portfolio of corporate loans and to issue notes to investors. The structure is designed so that the SPV is bankruptcy-remote, meaning it’s legally separate from everything else. If the structure collapses, it does so politely on its own.

Some CLOs are cash-flow structures, built on the actual income from the loans inside the box. Others are synthetic, meaning they don’t own the loans at all – they just take on the credit risk using derivatives. Either way, the core idea is the same: slice up the risk, share it out, and let the payment waterfall do the rest.

That’s the short version. If you’d like the full story – tranches, waterfalls, and why the equity investors get all the drama – take a peek at our earlier explainer, An Introduction to Collateralised Loan Obligations (CLOs)

The Arbitrage CLO – Playing the Spread

Now that we’ve dusted off the basics, let’s meet the first personality in our story: the Arbitrage CLO – the deal that’s in it for the money.

These are the show-offs of the CLO family, structured to make a return from the difference between what the loans inside the box earn and what it costs to borrow from investors. That difference – the arbitrage – is the fuel that powers the whole thing.

The setup is simple in principle (though rather less so in the paperwork):

• The SPV issues layers of notes, from cautious seniors at the top to optimistic equity investors at the bottom.
• The money raised buys a portfolio of corporate or leveraged loans.
• For several years – the reinvestment period – the manager can trade and replace loans within agreed limits to keep the performance on track.
• Any surplus income left after paying expenses and interest flows to the equity investors, who bear the first losses but also get the best upside.

An arbitrage CLO lives off the spread – earn more on the loans than it costs to fund them, and everyone’s happy.

The market today:

The arbitrage CLO still reigns supreme in structured credit. So far in 2025, U.S. broadly syndicated loan (BSL) issuance has already topped USD 80 billion, with resets and refinancings soaring beyond USD 130 billion. Across the pond, European issuance hit a record USD 18.3 billion in the first quarter alone – not bad for a market many wrote off after the last credit wobble.

Asset managers say the CLO equity arbitrage – the gap between what the loans earn and what it costs to fund them – remains wide enough to make it worth the trouble (and the spreadsheets). Even Fitch Ratings has been joining the applause, describing Apidos CLO LIV (August 2025) as a “cash-flow arbitrage CLO” – industry shorthand for “business as usual, but profitable.”

The arbitrage trade, in other words, is alive, well, and keeping lunches in Mayfair suspiciously well attended.

The Balance-Sheet CLO – The Regulator’s Favourite

If the Arbitrage CLO is built for profit, the Balance-Sheet CLO is built for peace of mind.
This one isn’t chasing yield – it’s there to make the regulators breathe a little easier.

Banks and credit institutions use these deals to move some of their credit risk off their balance sheets. By doing so, they reduce what’s known as their risk-weighted assets (RWAs) – the measure that dictates how much capital a bank must hold as a cushion against potential losses. Fewer risky loans on the books means less capital tied up, and a healthier capital ratio to show the supervisors.

All in all, it’s tidying up the balance sheet before the regulators start asking questions.

How it works:

• The bank (the originator) picks a portfolio of loans and transfers the risk on them to an SPV.
• This can be done by actually selling the loans – a true sale – or by keeping them on the books but transferring the risk through a credit derivative, such as a credit default swap (a synthetic structure).
• The SPV then issues notes to investors, who provide collateral and agree to shoulder the risk of borrower defaults up to the limits of their tranche.
• The bank keeps the safest slice and, if the structure passes muster, can apply to have the transaction recognised as significant risk transfer (SRT) under the Basel III capital rules.

What investors get:
They’re not earning an “arbitrage” spread here – they’re being paid a credit-risk premium, a coupon that compensates them for taking on a share of the loan losses. Their returns depend entirely on how the borrowers perform. Fewer defaults, happier investors.

The bigger picture:
For banks, these transactions are less about making a quick return and more about freeing up balance-sheet capacity. They allow new lending, stronger capital ratios, and slightly calmer compliance meetings.

So, while the Arbitrage CLO is out there making money, the Balance-Sheet CLO is keeping the supervisors sweet.

The Legal and Regulatory Bit

Every CLO depends on a small forest’s worth of legal documentation, but balance-sheet CLOs in particular live and die by the fine print.

To claim capital relief, a bank must prove that the credit risk has genuinely moved from its books to the investors. Lawyers line up to confirm it, producing opinions to show that if the loans go bad, it’s the investors – not the bank – who take the hit. Without that stamp of approval, the regulator simply won’t recognise the deal.

Arbitrage CLOs, meanwhile, are less about capital relief and more about investor protection. They fall under the UK and EU Securitisation Regulations, which set the ground rules:

• Managers must keep at least a 5 per cent stake, a polite way of saying: if you structure it, you share it.
• Investors must carry out their own due diligence and keep up with regular reporting.
• Everyone involved must disclose what’s in the portfolio and how it’s performing.

It’s a regulatory balancing act: enough transparency to protect investors, but just enough flexibility to keep the market moving.

The Last Word

On the surface, both types of CLO look much the same: same structure, same SPV, same waterfall of payments that everyone pretends to understand on the first read. But their motives couldn’t be more different.

• Arbitrage CLOs exist to earn – squeezing profit from the spread between what they make on loans and what they pay investors.
• Balance-Sheet CLOs exist to unload – shifting risk to keep the regulators on side.

One keeps portfolio managers busy chasing yield; the other keeps compliance teams busy chasing approval.

And that’s the curious thing about CLOs: identical architecture, entirely different ambitions. In the end, it all comes down to intent – whether you’re in it for the margin or for a little regulatory peace and quiet.